HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anton Stalc Selected Research

LK-732

3/2005Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anton Stalc Research Topics

Disease

1Thrombosis (Thrombus)
03/2005
1Thrombophilia
03/2005
1Venous Thrombosis (Deep-Vein Thrombosis)
03/2005
1Necrosis
01/2005
1Neoplasms (Cancer)
01/2005

Drug/Important Bio-Agent (IBA)

1amidoximeIBA
03/2005
1argatroban (MPQA)FDA Link
03/2005
1azaphenylalanineIBA
03/2005
1LK-732IBA
03/2005
1AntithrombinsIBA
03/2005
1Nadroparin (Nadroparin Calcium)IBA
03/2005
1ProdrugsIBA
03/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2005
1Basic Amino Acids (Basic Amino Acid)IBA
01/2005